The VDR, a ligand-activated transcription factor and a relevant prognostic marker for CRC patients, forms a heterocomplex with its main ligand VitD3, which subsequently prevents CRC and even inhibits CRC development and progression [7,36]. The gene discussed is VDR; the disease is colorectal carcinoma.